Last $65.46 USD
Change Today +0.76 / 1.17%
Volume 347.2K
MD On Other Exchanges
Symbol
Exchange
New York
Mexico
Frankfurt
As of 5:15 PM 11/28/14 All times are local (Market data is delayed by at least 15 minutes).

mednax inc (MD) Snapshot

Open
$64.86
Previous Close
$64.70
Day High
$66.05
Day Low
$64.72
52 Week High
11/28/14 - $66.05
52 Week Low
10/15/14 - $49.82
Market Cap
6.6B
Average Volume 10 Days
689.5K
EPS TTM
$3.07
Shares Outstanding
100.4M
EX-Date
--
P/E TM
21.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDNAX INC (MD)

Related News

No related news articles were found.

mednax inc (MD) Related Businessweek News

No Related Businessweek News Found

mednax inc (MD) Details

MEDNAX, Inc., together with its subsidiaries, provides newborn, anesthesia, maternal-fetal, and other pediatric subspecialties care physician services in the United States and Puerto Rico. It offers neonatal care services, including clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia care services through physician anesthesiologists, nurse anesthetists, anesthesia assistants, and other clinicians; anesthesia subspecialty care; and acute and chronic pain management services through outpatient medical offices, hospital clinics, and ambulatory service centers. The company also provides maternal-fetal care services comprising inpatient and office-based clinical care to expectant mothers and their unborn babies through affiliated maternal-fetal medicine subspecialists, obstetricians, and other clinicians, such as maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. Its pediatric cardiology care services consist of inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patients with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through pediatric cardiologist subspecialists and other clinicians; and other pediatric subspecialty care services include care of critically ill or injured children and adolescents; and clinical services in other areas of hospitals, primarily in the pediatric emergency room, labor and delivery area, and newborn nursery and pediatric department. MEDNAX, Inc. was founded in 1979 and is based in Sunrise, Florida.

6,500 Employees
Last Reported Date: 02/12/14
Founded in 1979

mednax inc (MD) Top Compensated Officers

Co-Founder, Chief Executive Officer, Director...
Total Annual Compensation: $1.0M
President and Chief Operating Officer
Total Annual Compensation: $600.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $400.0K
President of American Anesthesiology
Total Annual Compensation: $500.0K
President of Pediatrix Medical Group
Total Annual Compensation: $450.0K
Compensation as of Fiscal Year 2013.

mednax inc (MD) Key Developments

MEDNAX, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 11:30 AM

MEDNAX, Inc. Presents at Stifel Healthcare Conference 2014, Nov-18-2014 11:30 AM. Venue: The Palace Hotel, 455 Madison Ave, New York, NY 10022, United States. Speakers: Roger J. Medel, Co-Founder, Chief Executive Officer, Director and Chairman of Executive Committee.

MEDNAX Mulls Acquisitions

MEDNAX, Inc. (NYSE:MD) is looking for acquisition opportunities. Roger Medel, Chief Executive Officer of MEDNAX said, "We continue to see attractive opportunities in our acquisition pipeline, and have announced nine practice additions in 2014, including one in the third quarter and two so far in the fourth quarter."

MEDNAX, Inc. Announces Unaudited Consolidated Earnings Results for Third Quarter and Nine Months Ended Sept. 30, 2014; Provides Earnings Guidance for the Fourth Quarter Ended December 31, 2014

MEDNAX, Inc. announced unaudited consolidated earnings results for third quarter and nine months ended Sept. 30, 2014. For the quarter, the company’s net revenue was $626,506,000 against $554,730,000 a year ago. Income from operations was $138,143,000 against $123,291,000 a year ago. Income before income taxes was $137,412,000 against $122,156,000 a year ago. Net income attributable to the company was $86,207,000 or $0.86 per diluted share against $76,958,000 or $0.76 per diluted share a year ago. During the 2014 third quarter, the company generated cash flow from operations of $159.4 million, as compared to $157.9 million for the 2013 third quarter. For the year to date, the company’s net revenue was $1,788,389,000 against $1,586,625,000 a year ago. Income from operations was $371,913,000 against $328,214,000 a year ago. Income before income taxes was $369,743,000 against $325,015,000 a year ago. Net income attributable to the company was $228,883,000 or $2.28 per diluted share against $201,543,000 or $2.00 per diluted share a year ago. For the 2014 fourth quarter, the company expects earnings will be in a range of $0.83 to $0.87 per share. This outlook assumes that total same-unit revenue growth for the three months ended December 31, 2014 will grow by 2% to 4% from the prior-year period. The forecast estimates that this growth will be evenly divided between volume and net reimbursement-related factors. Included in the outlook for the 2014 fourth quarter is approximately $0.06 per share from Medicaid parity, reflecting the impacts from incentive compensation and income taxes, compared to $0.05 per share in the 2013 fourth quarter.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MD:US $65.46 USD +0.76

MD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
DENTSPLY International Inc $54.98 USD +0.46
HealthSouth Corp $41.13 USD +0.54
Hologic Inc $26.80 USD +0.32
Mettler-Toledo International Inc $293.26 USD -0.82
PerkinElmer Inc $45.47 USD -0.17
View Industry Companies
 

Industry Analysis

MD

Industry Average

Valuation MD Industry Range
Price/Earnings 21.1x
Price/Sales 2.7x
Price/Book 2.6x
Price/Cash Flow 18.5x
TEV/Sales 2.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDNAX INC, please visit www.mednax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.